Arq Inc

ARQ remains in a Stage 2 advance with medium-term bullish structure but recent weakness into flat short-term EMAs and high Stage Transition Risk suggests deferred entries. A speculative bias favors waiting for a pullback into rising EMAs or the prior consolidation range for evidence of absorption before commitment.

• ↑Launch of PAC for PFAS aligns ARQ with growing remediation market by 2027.
• ↑Q2 revenue up 5% YoY to $29.9M; gross margin expanded to 38.5%.
• ↓Full-year net loss of $52M and negative earnings yield highlight unprofitability.